Old Web
English
Sign In
Acemap
>
authorDetail
>
Tim Van Mouwerik
Tim Van Mouwerik
Prostate cancer
Medicine
Pathology
Internal medicine
in patient
3
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Predict: Evaluation of baseline characteristics predictive of distant metastases in patients with castration-resistant prostate cancer—Updated data.
2018
Journal of Clinical Oncology
Stephen J. Freedland
Matthew R. Smith
Raoul S. Concepcion
Christopher Michael Pieczonka
Benjamin A. Gartrell
Zvi Schiffman
Tim Van Mouwerik
Robert C. Tyler
Nancy N. Chang
Neal D. Shore
Show All
Source
Cite
Save
Citations (0)
Overall survival and immune responses with sipuleucel-T and enzalutamide: STRIDE study.
2018
Journal of Clinical Oncology
Daniel Peter Petrylak
Charles G. Drake
Christopher Michael Pieczonka
John M. Corman
Jorge A. Garcia
Curtis Dunshee
Tim Van Mouwerik
Robert C. Tyler
Nancy N. Chang
David I. Quinn
Show All
Source
Cite
Save
Citations (6)
PD14-06 SIPULEUCEL-T (SIP-T) WITH ENZALUTAMIDE (ENZ) (STRIDE): CLINICAL OUTCOMES IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) BY BASELINE (BL) PROSTATE-SPECIFIC ANTIGEN (PSA) QUARTILES
2018
The Journal of Urology
John M. Corman
Daniel Peter Petrylak
Charles G. Drake
Christopher Michael Pieczonka
Lawrence Karsh
Raoul S. Concepcion
Jorge A. Garcia
Curtis J. Dunshee
Tim Van Mouwerik
Robert C. Tyler
Nancy N. Chang
David I. Quinn
Show All
Source
Cite
Save
Citations (0)
1